Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd
Duopharma Biotech Berhad, the distributor of the Sinopharm vaccine, was one of the winners of the pandemic. But with a price cap set by the government, how will that impact the company? Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd answers those questions and their strategy for growth.
KKS marketing, offered lowest price of medical products in Kuching. If KKS Marketing open outlets in KL and Selangor, sure all the kedai ubat and pharmacy will surrender and tidak berani quoted high prices of medicinal products. Hope that KKS Marketing to open outlets in KL and Selangor. Even Alpro is tiada tandingan dengan KKS marketing.
QR is out : net profit rose 11.54% to RM22.63 million for 1QFY2023, from RM20.29 million a year earlier, on the back of higher revenue amid increased sales to the prescription pharmaceutical market. Earnings per share improved to 2.38 sen, from 2.19 sen in 1QFY2022, Quarterly revenue grew 7.82% to RM200.48 million from RM185.94 million.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....